Have a look through our FAQ section or get in touch if youd like to know more about our patented technology or anything we didnt cover.
[DOI] [PMC free article] [PubMed] [Google Scholar] 198.Kovacs GT
Explore real patient outcomes, dosing strategies, and what to expect in our full PT-141 guide
Pharmacists purchase semaglutide (the active ingredient in Ozempic, Wegovy, and Rybelsus) or tirzepatide (the active ingredient in Zepbound) and mix their own medications
As real-world data accumulates on minimal effective doses and long-term safety profiles, future medications might eventually meet the evidence bar for reduced oversightthough full OTC status remains speculative
Because each of the major studies for SGLT2is, GLP1-RAs, and nsMRAs added these newer therapies to participants on the maximum label or tolerated dose of an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB), it is suggested that cardiorenal protective therapy begin with either an ACEi or an ARB, titrated to either the label maximum or the maximum tolerated dose (see Table 1 for list of currently approved ACEi and ARB in Canada and the maximally recommended dosing)
